TRLVNYSEMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Trulieve Cannabis Corp.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$10.28+0.27 (+2.70%)
Close on Oct 19, 2026
- Market cap
- $1.98B
- P/E (TTM)
- –
- Dividend yield
- –
Margins
Share of revenue, fiscal years 2019 to 2025
Gross margin
60.2%−13.9 pts over 5 years
Operating margin
12.1%−29.7 pts over 5 years
Net margin
–
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | -0.4% | -1.0% | +17.8% | – | |
| Gross profit | -0.6% | +1.1% | +13.0% | – | |
| Operating income | +46.8% | +42.0% | -8.0% | – | |
| Free cash flow | +53.6% | – | – | – |
Returns and balance sheet
7 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2019 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on assets | – | – | – | |
| Current ratio | – | 3.43 | 4.43 | |
| Net debt to EBITDA | – | -0.62× | -0.63× | |
| Interest coverage | 12.5× | 10.8× | 2.3× | |
| Inventory turnover | – | – | 2.0× | |
| Capex to revenue | 28.4% | 19.2% | 3.7% | |
| Diluted shares | 115M | 118M | 191M |
Where the cash went
Fiscal 2021 to 2025, five years combined
Trulieve Cannabis generated $782.14M from operations and spent $647.68M on capital expenditure, dividends and share buybacks. 100% of that went back into the business.
Generated
$782.14M
Used
$647.68M
Capital expenditure$647.68M100%Dividends$00%Share buybacks$00%
DuPont needs revenue, assets and equity
This company does not report all three for consecutive years.
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
3of 6 tests passed in fiscal 2025. Some tests lack the figures they need.
- ProfitableNet income above zero–
- Cash generatingOperating cash flow above zero$272.82M
- Return on assets improvedROA up on the prior year– → –
- Earnings backed by cashOperating cash flow above net income$272.82M vs –
- Less leverageLong-term debt to assets fell3.9% → 3.4%
- Better liquidityCurrent ratio rose4.37 → 4.43
- No dilutionShare count did not rise190M → 191M
- Gross margin improvedGross margin up on the prior year60.32% → 60.21%
- More efficientAsset turnover rose0.43 → 0.41